ANIK- Anika Therapeutics, Inc.

Insider activity in ANIK over the last quarter tilts toward buying: insiders added a net 2,000 shares worth roughly $41K.

Classified under Pharmaceuticals (Health Care sector), ANIK's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
VP	Colleran David	67.6K	$959.5K	-
Dir	Henneman John B III	65.3K	-	-
Dir	Richard Stephen	58.3K	-	-
Dir	Fischetti Gary P	54.0K	$1.10M	-
Dir	Conley Sheryl L	53.0K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 4, 2026	Fischetti Gary P	Director	Buy	2,000	$20.53	$41,060.00	+3.8%	-	-
May 1, 2026	Henneman John B III	Director	Buy	5,000	$14.66	$73,319.50	+10.0%	+21.7%	-
Apr 30, 2026	Griffin Stephen D.	President And CEO	Buy	12,200	$12.29	$149,880.66	+50.9%	+29.9%	-
May 11, 2022	Colleran David	EVP, General Counsel, Corp Sec	Buy	1,500	$21.37	$32,055.00	+17.9%	+6.4%	+19.4%
Mar 14, 2022	Colleran David	EVP, General Counsel, Corp Sec	Buy	1,500	$26.65	$39,978.00	+21.8%	-19.6%	+5.7%
Mar 11, 2022	Thompson Jeffery S	Director	Buy	2,000	$24.66	$49,318.00	+13.2%	-14.2%	+2.0%
Mar 11, 2022	Blanchard Cheryl R	President, CEO, Director	Buy	8,100	$25.57	$207,142.82	+15.6%	-14.2%	+2.0%
Mar 11, 2022	Levitz Michael L	EVP, CFO, Treasurer	Buy	4,000	$24.62	$98,476.00	+33.5%	-14.2%	+2.0%
Aug 12, 2021	Levitz Michael L	EVP, CFO, Treasurer	Buy	3,627	$40.21	$145,826.39	+94.0%	-4.6%	-45.0%
May 18, 2021	Henneman John B III	Director	Buy	2,000	$42.86	$85,720.00	+21.5%	-0.6%	-48.6%